We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.21B
AUM Growth
+$158M
Cap. Flow
+$11.5M
Cap. Flow %
0.95%
Top 10 Hldgs %
38.56%
Holding
345
New
37
Increased
103
Reduced
110
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 18.58%
2 Healthcare 9.87%
3 Consumer Discretionary 9.58%
4 Financials 8.26%
5 Industrials 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
101
Cisco
CSCO
$457B
$1.45M 0.12%
29,001
-371,616
-93% -$18.5M
SHEL icon
102
Shell
SHEL
$254B
$1.37M 0.11%
20,450
+1,800
+10% +$115K
IQLT icon
103
iShares MSCI Intl Quality Factor ETF
IQLT
$13.8B
$1.31M 0.11%
32,998
+6,533
+25% +$249K
VCIT icon
104
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$1.26M 0.1%
15,613
+5,085
+48% +$408K
BNDX icon
105
Vanguard Total International Bond ETF
BNDX
$81.9B
$1.21M 0.1%
24,506
-4,520
-16% -$221K
SYF icon
106
Synchrony
SYF
$24.7B
$1.19M 0.1%
27,500
-14,800
-35% -$590K
VTV icon
107
Vanguard Morningstar Value ETF
VTV
$188B
$1.11M 0.09%
6,800
-125
-2% -$19.3K
LOAN
108
Manhattan Bridge Capital
LOAN
$47.5M
$1.09M 0.09%
215,885
-3,500
-2% -$16.8K
GWW icon
109
W.W. Grainger
GWW
$65.3B
$1.07M 0.09%
1,050
-125
-11% -$117K
PGX icon
110
Invesco Preferred ETF
PGX
$3.81B
$1.06M 0.09%
89,055
-16,751
-16% -$197K
MA icon
111
Mastercard
MA
$502B
$979K 0.08%
2,033
-10
-0.5% -$4.57K
XYL icon
112
Xylem
XYL
$27.3B
$978K 0.08%
7,565
-838
-10% -$101K
BSCR icon
113
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
$973K 0.08%
+50,417
New +$974K
EFAV icon
114
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.34B
$959K 0.08%
13,528
+1,621
+14% +$113K
BSCT icon
115
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.91B
$917K 0.08%
+50,102
New +$917K
DE icon
116
Deere & Co
DE
$160B
$900K 0.07%
2,190
RNP icon
117
Cohen & Steers REIT and Preferred and Income Fund
RNP
$988M
$896K 0.07%
42,600
-2,900
-6% -$59.2K
RTX icon
118
RTX Corp
RTX
$290B
$883K 0.07%
9,049
+2,000
+28% +$181K
CBRE icon
119
CBRE Group
CBRE
$42.5B
$881K 0.07%
9,065
-6,135
-40% -$551K
HD icon
120
Home Depot
HD
$331B
$881K 0.07%
2,297
+570
+33% +$208K
IBTH icon
121
iShares iBonds Dec 2027 Term Treasury ETF
IBTH
$2.25B
$867K 0.07%
+39,135
New +$870K
QQQ icon
122
Invesco QQQ Trust
QQQ
$453B
$856K 0.07%
1,929
+155
+9% +$66.5K
RQI icon
123
Cohen & Steers Quality Income Realty Fund
RQI
$1.7B
$835K 0.07%
69,100
+32,300
+88% +$384K
ICSH icon
124
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.07B
$820K 0.07%
16,209
+7,706
+91% +$389K
XRN
125
Chiron Real Estate Inc
XRN
$514M
$782K 0.06%
17,870
+50
+0.3% +$2.4K

Similar funds

Shufro Rose & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Shufro Rose & Co held 345 positions worth $1.21B, up 15% from $1.05B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Shufro Rose & Co's Q1 2024 filing shows 37 new, 103 increased, 110 reduced and 29 closed positions. Its largest new stake was Moderna: 146,584 shares worth $15.6M. The largest sale was iShares iBonds Dec 2026 Term Corporate ETF, an estimated $41.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Shufro Rose & Co's largest Q1 2024 buy was Moderna: 146,584 shares worth $15.6M.
  • Shufro Rose & Co added most to iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024, an estimated $121M increase.
  • Shufro Rose & Co's biggest Q1 2024 reduction was iShares iBonds Dec 2026 Term Corporate ETF, cutting an estimated $41.5M.
  • Shufro Rose & Co fully exited Horizon Kinetics Inflation Beneficiaries ETF in Q1 2024, selling an estimated $34.8M.
  • Shufro Rose & Co's ten largest holdings make up 39% of its $1.21B portfolio in Q1 2024.
  • Shufro Rose & Co opened 37 new positions and closed 29 in Q1 2024.
  • Shufro Rose & Co's portfolio value rose 15% quarter-over-quarter to $1.21B.

Based on Shufro Rose & Co's 13F filing for Q1 2024, filed 8 May 2024.